COVID-19 Vaccine Safety–Anaphylaxis and Allergic Reactions

<p>Tom Shimabukuro, MD, MPH, MBA, and Sara Mbaeyi, MD, MPH, from the CDC discuss rare allergic complications in patients who received the first dose of the Pfizer-BioNTech vaccine between December 14-23, 2020.</p>